US Stocks Movement: Eli Lilly Surges on October 15—Defensive Sector Rotation and Omvoh Clinical Data

Eli Lilly October 15th Surge Analysis

Keywords: Defensive sector rotation, Omvoh clinical data

1. After the U.S. September CPI exceeded expectations on October 14th, funds shifted from AI technology stocks to defensive sectors such as healthcare; Eli Lilly, as a pharmaceutical leader, continued the sector's upward trend.

2. On October 15th, Eli Lilly released one-year Omvoh study data: 27.7% of ulcerative colitis patients achieved complete disease control, and 20.4% of Crohn's disease patients attained steroid-free deep remission; the relevant data came from the LUCENT-2 and VIVID-1 studies.

(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only—it does not constitute investment advice.)